Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel Free LABS Stock Alerts

MediPharm Labs (LABS) Competitors

MediPharm Labs logo
C$0.07 +0.01 (+7.69%)
As of 07/3/2026 03:59 PM Eastern
Compare

LABS vs. TGOD, NINE, DB, WMD, and HEXO

Should you buy MediPharm Labs stock or one of its competitors? MarketBeat compares MediPharm Labs with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with MediPharm Labs include Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), Decibel Cannabis (DB), WeedMD (WMD), and HEXO (HEXO). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does MediPharm Labs compare to Green Organic Dutchman?

Green Organic Dutchman (TSE:TGOD) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, profitability, valuation and earnings.

0.3% of MediPharm Labs shares are held by institutional investors. 4.5% of MediPharm Labs shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

MediPharm Labs has higher revenue and earnings than Green Organic Dutchman. MediPharm Labs is trading at a lower price-to-earnings ratio than Green Organic Dutchman, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Green Organic DutchmanC$31.37M0.00-C$137.58M-C$0.26N/A
MediPharm LabsC$43.28M0.69-C$12.05M-C$0.02N/A

In the previous week, Green Organic Dutchman's average media sentiment score of 0.00 equaled MediPharm Labs'average media sentiment score.

Company Overall Sentiment
Green Organic Dutchman Neutral
MediPharm Labs Neutral

Green Organic Dutchman has a net margin of 0.00% compared to MediPharm Labs' net margin of -20.21%. Green Organic Dutchman's return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Green Organic DutchmanN/A N/A N/A
MediPharm Labs -20.21%-23.55%-7.17%

Summary

MediPharm Labs beats Green Organic Dutchman on 5 of the 9 factors compared between the two stocks.

How does MediPharm Labs compare to Delta 9 Cannabis?

MediPharm Labs (TSE:LABS) and Delta 9 Cannabis (CVE:NINE) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, valuation, earnings, institutional ownership and dividends.

In the previous week, MediPharm Labs' average media sentiment score of 0.00 equaled Delta 9 Cannabis'average media sentiment score.

Company Overall Sentiment
MediPharm Labs Neutral
Delta 9 Cannabis Neutral

Delta 9 Cannabis has a net margin of 0.00% compared to MediPharm Labs' net margin of -20.21%. Delta 9 Cannabis' return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
MediPharm Labs-20.21% -23.55% -7.17%
Delta 9 Cannabis N/A N/A N/A

Delta 9 Cannabis has lower revenue, but higher earnings than MediPharm Labs. MediPharm Labs is trading at a lower price-to-earnings ratio than Delta 9 Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$43.28M0.69-C$12.05M-C$0.02N/A
Delta 9 CannabisC$12.87M6.94C$4.69MC$0.0519.07

0.3% of MediPharm Labs shares are held by institutional investors. 4.5% of MediPharm Labs shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Delta 9 Cannabis beats MediPharm Labs on 7 of the 10 factors compared between the two stocks.

How does MediPharm Labs compare to Decibel Cannabis?

MediPharm Labs (TSE:LABS) and Decibel Cannabis (CVE:DB) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, earnings, dividends, profitability, analyst recommendations, valuation and risk.

In the previous week, Decibel Cannabis had 2 more articles in the media than MediPharm Labs. MarketBeat recorded 2 mentions for Decibel Cannabis and 0 mentions for MediPharm Labs. Decibel Cannabis' average media sentiment score of 1.45 beat MediPharm Labs' score of 0.00 indicating that Decibel Cannabis is being referred to more favorably in the news media.

Company Overall Sentiment
MediPharm Labs Neutral
Decibel Cannabis Positive

Decibel Cannabis has a net margin of -3.78% compared to MediPharm Labs' net margin of -20.21%. Decibel Cannabis' return on equity of -1.05% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
MediPharm Labs-20.21% -23.55% -7.17%
Decibel Cannabis -3.78%-1.05%3.04%

Decibel Cannabis has higher revenue and earnings than MediPharm Labs. Decibel Cannabis is trading at a lower price-to-earnings ratio than MediPharm Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$43.28M0.69-C$12.05M-C$0.02N/A
Decibel CannabisC$121.32M0.55-C$1.03M-C$0.01N/A

Decibel Cannabis has a consensus target price of C$0.18, indicating a potential upside of 52.17%. Given Decibel Cannabis' stronger consensus rating and higher probable upside, analysts clearly believe Decibel Cannabis is more favorable than MediPharm Labs.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MediPharm Labs
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Decibel Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50

MediPharm Labs has a beta of -0.614829, meaning that its share price is 161% less volatile than the broader market. Comparatively, Decibel Cannabis has a beta of -0.074057, meaning that its share price is 107% less volatile than the broader market.

0.3% of MediPharm Labs shares are held by institutional investors. Comparatively, 0.7% of Decibel Cannabis shares are held by institutional investors. 4.5% of MediPharm Labs shares are held by insiders. Comparatively, 1.1% of Decibel Cannabis shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Decibel Cannabis beats MediPharm Labs on 14 of the 17 factors compared between the two stocks.

How does MediPharm Labs compare to WeedMD?

WeedMD (CVE:WMD) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

0.3% of MediPharm Labs shares are owned by institutional investors. 4.5% of MediPharm Labs shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, WeedMD's average media sentiment score of 0.00 equaled MediPharm Labs'average media sentiment score.

Company Overall Sentiment
WeedMD Neutral
MediPharm Labs Neutral

WeedMD has a net margin of 0.00% compared to MediPharm Labs' net margin of -20.21%. WeedMD's return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
WeedMDN/A N/A N/A
MediPharm Labs -20.21%-23.55%-7.17%

MediPharm Labs has higher revenue and earnings than WeedMD. MediPharm Labs is trading at a lower price-to-earnings ratio than WeedMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WeedMDC$27.53M2.46-C$102.60M-C$0.42N/A
MediPharm LabsC$43.28M0.69-C$12.05M-C$0.02N/A

Summary

WeedMD and MediPharm Labs tied by winning 5 of the 10 factors compared between the two stocks.

How does MediPharm Labs compare to HEXO?

MediPharm Labs (TSE:LABS) and HEXO (TSE:HEXO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership.

MediPharm Labs has higher earnings, but lower revenue than HEXO. MediPharm Labs is trading at a lower price-to-earnings ratio than HEXO, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$43.28M0.69-C$12.05M-C$0.02N/A
HEXOC$124.10M0.00-C$273.18M-C$3.41N/A

0.3% of MediPharm Labs shares are held by institutional investors. Comparatively, 7.6% of HEXO shares are held by institutional investors. 4.5% of MediPharm Labs shares are held by company insiders. Comparatively, 3.0% of HEXO shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

MediPharm Labs has a beta of -0.614829, suggesting that its share price is 161% less volatile than the broader market. Comparatively, HEXO has a beta of 2.13, suggesting that its share price is 113% more volatile than the broader market.

In the previous week, MediPharm Labs' average media sentiment score of 0.00 equaled HEXO'saverage media sentiment score.

Company Overall Sentiment
MediPharm Labs Neutral
HEXO Neutral

MediPharm Labs has a net margin of -20.21% compared to HEXO's net margin of -220.13%. MediPharm Labs' return on equity of -23.55% beat HEXO's return on equity.

Company Net Margins Return on Equity Return on Assets
MediPharm Labs-20.21% -23.55% -7.17%
HEXO -220.13%-106.39%-14.96%

Summary

MediPharm Labs beats HEXO on 6 of the 10 factors compared between the two stocks.

Get MediPharm Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LABS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LABS vs. The Competition

Export
MetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$29.74MC$6.60BC$7.17BC$13.07B
Dividend YieldN/A2.83%2.66%6.18%
P/E Ratio-3.505.1128.0236.51
Price / Sales0.691,653.39540.7210.34
Price / Cash1.3010.1849.2682.29
Price / Book0.8510.8310.964.52
Net Income-C$12.05MC$20.27BC$3.57BC$299.09M
7 Day PerformanceN/A1.30%2.12%1.85%
1 Month PerformanceN/A-1.17%5.25%1.71%
1 Year PerformanceN/A9.82%33.29%36.40%

MediPharm Labs Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LABS
MediPharm Labs
N/AC$0.07
+7.7%		N/A+7.7%C$29.74MC$43.28MN/A130
TGOD
Green Organic Dutchman
N/AN/AN/AN/AC$89.95MC$31.37MN/A41
NINE
Delta 9 Cannabis
N/AC$1.03
+3.0%		N/A+0.0%C$89.36MC$12.87M19.07940
DB
Decibel Cannabis
3.6823 of 5 stars		C$0.12
flat		C$0.18
+45.8%		+53.3%C$69.25MC$121.32MN/A83,000
WMD
WeedMD
N/AC$0.28
-1.8%		N/A+0.0%C$67.82MC$27.53MN/A628

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:LABS) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel